Childhood Spinal Cord Neoplasm Completed Phase 2 / 3 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0030212 (Childhood Spinal Cord Neoplasm)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01236560Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaTreatment